Press releases

(February 22, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in its ATLAS clinical trial. ATLAS is the first trial using Boston Scientific's...

(February 16, 2005) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the Interventional Procedures Advisory Committee (IPAC) of the United Kingdom's National...

(February 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference, which is...

and New York, NY (February 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today provided financial guidance for 2005 and announced financial goals for 2006 and 2007 at a meeting with...

(January 31, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has completed the initial launch of its TAXUS® Liberté™ paclitaxel-eluting coronary stent system. On...

(January 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) will simultaneously webcast the analyst meeting it is hosting on Tuesday, February 1. The meeting is scheduled to begin at 9:00 a.m....

(January 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2005 Piper Jaffray Health Care Conference, which is being held January 25-27 in New York City....

(January 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the implantation of its millionth TAXUS® Express2™ paclitaxel-eluting coronary stent system, marking a major...

(January 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has launched its TAXUS™ Liberté™ paclitaxel-eluting coronary stent system in 18 countries. The TAXUS...

and San Francisco, CA (January 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced preliminary, unaudited sales results for the fourth quarter and for the year ended December...

(January 6, 2005)-- Boston Scientific Corporation (NYSE: BSX) announced today that the U.S. District Court in Delaware has granted summary judgment of non-infringement in favor of Boston...

(January 4, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 23rd Annual JPMorgan Healthcare Conference, which is being held January 10-13 in San Francisco....

and New York, NY (February 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for the fourth quarter and for the year ended December 31, 2004 at a meeting with...

(December 30, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is donating $100,000 to the Red Cross for tsunami relief. The money is being directed to the Red Cross'...

(December 20, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced an expansion of its management structure designed to position the Company for continued growth and success. The...

(December 16, 2004) -- Boston Scientific Corporation (NYSE:BSX) today announced that it has entered into a definitive agreement to acquire Advanced Stent Technologies, Inc. (AST) of Pleasanton,...

(December 2, 2004) -- Boston Scientific Corporation (NYSE: BSX) today commented on a ruling by the U.S. District Court for the Southern District of New York on preliminary motions in a breach of...

(November 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its Intravascular Ultrasound (IVUS) procedures have been recognized for payment under a new Medicare...

(November 24, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Lazard Frères First Annual Life Sciences Conference, which will take place November 30 and...

(November 23, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it had exercised its right under an existing licensing agreement with Angiotech Pharmaceuticals, Inc. (NASDAQ:...

(November 22, 2004) -- Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the French government that it has added new categories of "high-risk" patients to the...

(November 18, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its public offering of $250 million aggregate principal amount of its 4.250 percent senior notes...

(November 16, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has made an equity investment in -- and secured an exclusive option to purchase -- REVA Medical, Inc., a...

(November 15, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today the launch of a public offering of two series of its senior notes under the Company's existing shelf registration...

(November 12, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Credit Suisse First Boston Healthcare Conference 2004, which is being held November 17-19 in...